EPIRUS Biopharmaceuticals, Inc. (EPRS) financial statements (2022 and earlier)

Company profile

Business Address 699 BOYLSTON ST
BOSTON, MA 02116
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments31,51521,46217,9584,531
Cash and cash equivalents31,51521,46217,9584,531
Receivables  2,5113,045
Prepaid expense668633 
Prepaid expense and other current assets684
Other current assets653461 
Other undisclosed current assets2,41146227330,109
Total current assets:35,24723,01820,74238,369
Noncurrent Assets
Property, plant and equipment2,0737042,3633,535
Intangible assets, net (including goodwill)32,77121,8637,20017,654
Goodwill26,36116,363  
Intangible assets, net (excluding goodwill)6,4105,5007,20017,654
Restricted cash and investments1,9241,8251,8011,817
Other noncurrent assets249374 
Other undisclosed noncurrent assets 3,605  
Total noncurrent assets:37,01728,37111,36423,006
TOTAL ASSETS:72,26451,38932,10661,375
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities7,0327,8996,2329,798
Accounts payable2,0512,4832,2373,261
Accrued liabilities4,0034,1013,3394,841
Employee-related liabilities 1,2446561,696
Interest and dividends payable 71  
Settlement liabilities978 
Debt14,833 6,64012,822
Deferred revenue and credits957502,3924,918
Deferred tax liabilities185185  
Other liabilities343557  
Other undisclosed current liabilities9,931(1,315)(372)(7,907)
Total current liabilities:33,2817,37614,89219,631
Noncurrent Liabilities
Long-term debt and lease obligation 7,2822,1328,772
Long-term debt, excluding current maturities 7,2822,1328,772
Liabilities, other than long-term debt1,9672,1643091,071
Deferred revenue and credits1,1739463091,057
Deferred tax liabilities, net369553  
Other liabilities425665 14
Other undisclosed noncurrent liabilities648   
Total noncurrent liabilities:2,6159,4462,4419,843
Total liabilities:35,89616,82217,33329,474
Stockholders' equity
Stockholders' equity attributable to parent36,36832,40114,18231,026
Common stock241326127
Additional paid in capital175,126118,959393,796371,912
Accumulated other comprehensive income (loss)(23)  10
Accumulated deficit(138,759)(86,571)(379,640)(341,023)
Total stockholders' equity:36,36832,40114,18231,026
Other undisclosed liabilities and equity 2,166591875
TOTAL LIABILITIES AND EQUITY:72,26451,38932,10661,375

Income statement (P&L) ($ in thousands)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues
(Revenue, Net)
701414,73112,550
Cost of revenue
(Cost of Goods and Services Sold)
(125)   
Gross profit:576414,73112,550
Operating expenses(52,876)(39,259)(51,941)(55,386)
Operating loss:(52,300)(39,255)(37,210)(42,836)
Nonoperating income (expense)(432)(2,632)60241
Investment income, nonoperating  46150
Other nonoperating income (expense)(116)2621491
Interest and debt expense (22)(1,467)(2,173)
Other undisclosed income from continuing operations before equity method investments, income taxes 22  
Loss from continuing operations before income taxes:(52,732)(41,887)(38,617)(44,768)
Income tax benefit54443 441
Net loss available to common stockholders, diluted:(52,188)(41,844)(38,617)(44,327)

Comprehensive Income ($ in thousands)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss:(52,188)(41,844)(38,617)(44,327)
Comprehensive loss:(52,188)(41,844)(38,617)(44,327)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(23) (10)18
Comprehensive loss, net of tax, attributable to parent:(52,211)(41,844)(38,627)(44,309)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: